© 2005-2012 American Society of Clinical Oncology (ASCO). All rights reserved worldwide.
Find out about the basics of cancer care, particularly helpful if you or a loved one has been newly diagnosed with cancer.
The Internet is a useful tool for finding information about cancer and connecting with other patients and caregivers. However, it can be difficult to find credible, reliable information about cancer causes, risk factors, treatment, and recovery. Because Internet content is not regulated, you need to use good judgment when searching online.
Cancer clinical trials have led to scientific advances in the prevention, care, and treatment of people with cancer. This knowledge could not have been attained without the participation of patients and their doctors. To understand how patient advocates help advance cancer research, Cancer.Net welcomes George W. Sledge Jr., MD, the 2010-2011 President of the American Society of Clinical Oncology, and Mary Lou Smith, a longtime patient advocate. Dr. Sledge and Ms. Smith have worked together for many years, primarily through the Eastern Cooperative Oncology Group, a clinical cancer research organization.
This article is the second part of a two-part series on drug development and approval. It describes the drug development and approval process in more depth, covering fast track programs, orphan drugs, off-label use, and patient involvement.
Each year a variety of new drugs, including new uses for existing drugs, become available for people with cancer. This article explains how these drugs go from being an idea in the laboratory to a labeled vial in the doctor's office. Drug Development and Approval, Part II explains the drug development and approval in more depth.